Critical testing and parameters for consideration when manufacturing and evaluating tumor–associated antigen-specific T cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Critical testing and parameters for consideration when manufacturing and evaluating tumor–associated antigen-specific T cells

Published:2019-03 Issue:3 Volume:21 Page:278-288
ISSN:1465-3249
Container-title:Cytotherapy
language:en
Short-container-title:Cytotherapy

Author:

Tanna Jay G.,Ulrey Robert,Williams Kirsten M.,Hanley Patrick J.

Funder

Children's Cancer Foundation

Leukemia and LymphomaSociety

Publisher

Elsevier BV

Subject

Cancer Research,Transplantation,Cell Biology,Genetics(clinical),Oncology,Immunology,Immunology and Allergy

Reference76 articles.

1. Considerations in T Cell therapy product development for b cell leukemia and lymphoma immunotherapy;Fesnak;Curr Hematol Malig Rep,2017

2. Current status of gene engineering cell therapeutics;Saudemont;Front Immunol,2018

3. Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma;Neelapu;N Engl J Med,2017

4. Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia;Maude;N Engl J Med,2018

5. Chimeric antigen receptor T cells in refractory B-cell lymphomas;Schuster;N Engl J Med,2017

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chick Embryo Chorioallantoic Membrane as a Platform for Assessing the In Vivo Efficacy of Chimeric Antigen Receptor T-cell Therapy in Solid Tumors;ImmunoHorizons;2024-08-01

2. Environmental monitoring of current good manufacturing practices cleanroom facilities for manufacturing of cellular therapy products in an academic hospital setting;Cytotherapy;2024-06

3. Review of flow cytometry as a tool for cell and gene therapy;Cytotherapy;2024-02

4. Basics of advanced therapy medicinal product development in academic pharma and the role of a GMP simulation unit;Immuno-Oncology and Technology;2023-12

5. Production and characterization of virus-free, CRISPR-CAR T cells capable of inducing solid tumor regression;Journal for ImmunoTherapy of Cancer;2022-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3